Neurotech Devices Global Market Outlook Report 2023: Market Revenue Data for 2021, Estimates for 2022, 2023, 2025, and CAGR Projections through 2027
February 14, 2023 09:38 ET
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurotech Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market is segmented based...
Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALS
January 17, 2023 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company...
Global Neurotechnology Market Report 2022: The Definitive Report on Neuromodulation, Neuroprosthetics, Neurodiagnostics, and Neurorehabilitation Devices
August 10, 2022 05:13 ET
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "The Market for Neurotechnology: 2022-2026" report has been added to ResearchAndMarkets.com's offering. Overall worldwide market for neurotechnology...
Global Invasive Brain-Computer interface (BCI) Market Research Report 2022: Real-time Decoding of Macroscopic Brain States Becomes Critical
June 14, 2022 05:43 ET
|
Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Market Overview of Invasive Brain-Computer interface (BCI)" report has been added to ResearchAndMarkets.com's offering. Patients with Locked-in...
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
March 07, 2022 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
October 21, 2021 05:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada
December 07, 2018 05:00 ET
|
Heuro Canada
SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative neurological health solutions, is championing a new therapeutic paradigm for...
Newly Published Market Research Report Projects Neurotechnology Market Will Reach $13.3B by 2022
April 23, 2018 08:03 ET
|
Neurotech Reports
SAN FRANCISCO, April 23, 2018 (GLOBE NEWSWIRE) -- A newly published market research report from Neurotech Reports predicts that the global market for neurotechnology products will be $8.4 billion in...
Patient-Centered Primary Care Collaborative CEO Marci Nielsen To Kick-Off The 2013 OPEN MINDS Technology & Informatics Institute
October 01, 2013 10:03 ET
|
Open Minds
GETTYSBURG, Pa., Oct. 1, 2013 (GLOBE NEWSWIRE) -- OPEN MINDS has announced that Marci Nielsen, Ph.D., MPH, Chief Executive Officer, Patient-Centered Primary Care Collaborative (PCPCC) will open The...
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
July 19, 2010 08:00 ET
|
The Magnum Group
TIBURON, CA--(Marketwire - July 19, 2010) - NovaVision, Inc., headquartered in Boca Raton, Fla., filed for Chapter 7 Bankruptcy in the State of Florida (Case #10-21343-PGH) on April 28, 2010...